Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review

Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Abiomed Inc (Abiomed) is a medical device company that develops, manufactures and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc Key Recent Developments

May 31,2022: Abiomed to Present at the William Blair 42nd Annual Growth Stock Conference
Apr 28,2022: Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year
Apr 08,2022: Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification
Mar 21,2022: Abiomed to Host Investor Call on Impella ECP, the World’s Smallest Heart Pump at 9 French
Feb 08,2022: Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Abiomed Inc - Key Facts
Abiomed Inc - Key Employees
Abiomed Inc - Key Employee Biographies
Abiomed Inc - Major Products and Services
Abiomed Inc - History
Abiomed Inc - Company Statement
Abiomed Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Abiomed Inc - Business Description
Product Category: Impella Product Revenue
Overview
Performance
Product Category: Service and Other Revenue
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: International
Performance
Geographical Segment: Japan
Performance
Geographical Segment: The US
Performance
R&D Overview
Abiomed Inc - Corporate Strategy
Abiomed Inc - SWOT Analysis
SWOT Analysis - Overview
Abiomed Inc - Strengths
Abiomed Inc - Weaknesses
Abiomed Inc - Opportunities
Abiomed Inc - Threats
Abiomed Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Abiomed Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
Abiomed Inc, Medical Equipment, Deals By Type, 2016 to YTD 2022
Abiomed Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 31, 2022: Abiomed to Present at the William Blair 42nd Annual Growth Stock Conference
Apr 28, 2022: Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year
Apr 08, 2022: Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification
Mar 21, 2022: Abiomed to Host Investor Call on Impella ECP, the World’s Smallest Heart Pump at 9 French
Feb 08, 2022: Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference
Jan 14, 2022: Abiomed Third Quarter Fiscal 2022 Earnings and Conference Call Notification
Dec 29, 2021: Abiomed to Present at the 40th Annual J.P. Morgan Healthcare Conference
Nov 18, 2021: Abiomed to Present at Upcoming Investor Conferences
Oct 28, 2021: Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year
Apr 28, 2021: Dr. Paula A. Johnson Joins Abiomed Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Abiomed Inc, Key Facts
Abiomed Inc, Key Employees
Abiomed Inc, Key Employee Biographies
Abiomed Inc, Major Products and Services
Abiomed Inc, History
Abiomed Inc, Subsidiaries
Abiomed Inc, Key Competitors
Abiomed Inc, Annual Ratios
Abiomed Inc, Annual Ratios (Cont...1)
Abiomed Inc, Annual Ratios (Cont...2)
Abiomed Inc, Interim Ratios
Abiomed Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
Abiomed Inc, Medical Equipment, Deals By Type, 2016 to YTD 2022
Abiomed Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Abiomed Inc, Performance Chart (2018 - 2022)
Abiomed Inc, Ratio Charts
Abiomed Inc, Medical Equipment, Deals By Year, 2016 to YTD 2022
Abiomed Inc, Medical Equipment, Deals by Type, 2016 to YTD 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook